Japanese encephalitis virus vaccine SA14-14-2 and Ramucirumab Intravenous
Determining the interaction of Japanese encephalitis virus vaccine SA14-14-2 and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: japanese enceph vacc sa14-14-2, inactivated
Brand name: Ixiaro
Synonyms: Japanese encephalitis virus vaccine (SA14-14-2), Japanese Encephalitis Virus Vaccine (Inactivated)
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Japanese encephalitis virus vaccine SA14-14-2-Ranexa
- Japanese encephalitis virus vaccine SA14-14-2-Ranibizumab
- Japanese encephalitis virus vaccine SA14-14-2-Ranibizumab Intraocular
- Japanese encephalitis virus vaccine SA14-14-2-Ranibizumab ophthalmic
- Japanese encephalitis virus vaccine SA14-14-2-Ranitidine
- Japanese encephalitis virus vaccine SA14-14-2-Ranitidine Capsule
- Ramucirumab Intravenous-Jardiance
- Ramucirumab Intravenous-Jasmiel
- Ramucirumab Intravenous-Jatenzo
- Ramucirumab Intravenous-Jay-Phyl
- Ramucirumab Intravenous-Jay-Phyl Syrup
- Ramucirumab Intravenous-Jencycla